Dosage guide
N-Acetyl Cysteine dosage
N-Acetyl Cysteine dosing: typical range, frequency, half-life, onset, routes. Evidence-tiered.
At a glance
- Typical dose
- 1200mg
- Half-life
- 5.6hr
- Frequency
- 1 to 3 times daily, split dosing preferred
- Routes
- oral, iv
Protocol
- 1
Measure the dose
Typical N-Acetyl Cysteine dose is 1200 mg. Use a weight-based calculator for individual adjustments.
Open tool → - 2
Set the frequency
Administer 1 to 3 times daily, split dosing preferred. Half-life of 5.6 hours anchors the dosing interval.
Open tool → - 3
Cycle if needed
Typically used continuously; some users pulse for specific goals like hangover or training blocks
Open tool → - 4
Monitor for side effects
Watch for: sulfur-like taste or odor; nausea; flatulence; diarrhea. Stop or reduce dose if tolerability breaks down.
Why this dose
Deacetylated to cysteine, the rate-limiting precursor for glutathione synthesis; also directly scavenges reactive oxygen species and modulates glutamate signaling.
The typical 1200 mg dose is the figure most commonly used in published protocols for N-Acetyl Cysteine. Treat the label as a starting point: body weight, training status, sleep, diet, and concurrent medications all shift the effective dose-response curve in real users.
How to administer
N-Acetyl Cysteine is administered via the oral or iv routes. Oral dosing is straightforward: take with water, with or without food unless specifically noted.
Onset of action runs around 1 hour after administration. Peak effect lands near 2 hours post-dose. Plan the administration window so that peak effect lines up with whatever outcome you are dosing for, whether that is training, sleep, or symptom coverage.
Half-life note: ~2 to 6 hours oral; IV formulations differ by protocol
Cycling and tolerance
Typically used continuously; some users pulse for specific goals like hangover or training blocks
Effects to expect at typical dose
- Replenishes intracellular glutathione by supplying cysteine, the rate-limiting amino acid for synthesis
- First-line antidote for acetaminophen toxicity, restoring hepatic glutathione before fulminant injury occurs
- Reduces sputum viscosity in chronic bronchitis and COPD at 600 to 1200 mg/day over months
- Modest symptom reductions in OCD and trichotillomania at 1200 to 2400 mg/day across small RCTs
- Mixed evidence for psychiatric adjunct use in bipolar depression and schizophrenia negative symptoms
- Inhaled forms can trigger bronchospasm in active asthma; oral use is the standard biohacker route
Best-graded outcomes
- A Acetaminophen toxicity reversal : Established first-line antidote (Acute APAP overdose).
- B Mucolysis in chronic bronchitis and COPD : Reduced sputum viscosity at 600 to 1200 mg (Chronic bronchitis, COPD).
- B Glutathione synthesis : Replenishes intracellular glutathione (Adults with depleted GSH).
Side effects and interactions
Common side effects
- sulfur-like taste or odor
- nausea
- flatulence
- diarrhea
Notable interactions
- nitroglycerin (moderate): potentiates vasodilation, risk of hypotension and headache
- activated charcoal (moderate): reduces NAC absorption when used for acetaminophen overdose
- anticoagulants (minor): theoretical additive antiplatelet effect at high doses
Lists above cover commonly reported and well-characterized items. They are not exhaustive: review the full N-Acetyl Cysteine profile and discuss with a clinician familiar with your medication list before starting, particularly if you are on prescription therapy or have a chronic condition.
Regulatory snapshot
- WADA status
- allowed
- DEA / Rx
- OTC supplement (US, post-2022); Rx indications also exist (acetaminophen overdose, mucolytic)
- Pregnancy
- Used clinically in pregnancy for specific indications; consult clinician
- Legal status
- OTC in most jurisdictions; restricted periods in US history (FDA reclassified 2022)
Do not use if
- active asthma attack (inhaled form can trigger bronchospasm)
- known NAC hypersensitivity
Related calculators
Related research